Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4103/ijo.IJO_1003_16 http://scihub22266oqcxt.onion/10.4103/ijo.IJO_1003_16 C5598194!5598194 !28820169     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28820169 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28820169 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Indian+J+Ophthalmol 2017 ; 65 (8 ): 758-760 Nephropedia Template TP {{tp|p=28820169 |t=2017. Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience |pdf=|usr=}}{{28820169 }} gab.com Text Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience JO: Indian J Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=28820169 #FOAvip Treatment guidelines for symptomatic polypoidal choroidal vasculopathy (PCV) have been described, but the management of recurrent or recalcitrant PCV is a challenge. The newer anti-vascular endothelial growth factor: aflibercept has shown promise in the treatment of both treatment naive and recalcitrant PCV in studies outside India. We present the minimum 6 months results of intravitreal aflibercept in recurrent and recalcitrant PCV in Indian eyes after multiple injections of bevacizumab/ranibizumab with or without photodynamic therapy. Of 10 eyes, 7 resolved of which 4 recurred needing continued aflibercept. Three of the ten eyes did not show a response. To the best of our knowledge, this is the first report from India in this challenging situation. Twit Text FOAVip Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience ????Indian J Ophthalmol http://www.kidney.de/pget.php?&tw=1&pmid=28820169 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28820169 #FOAvip English Wikipedia <ref>{{Cite pmid|28820169 }}</ref> Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience #MMPMID28820169 Bansal A ; Bhende M ; Sharma T ; Bhende P ; Mukherjee S Indian J Ophthalmol 2017[Aug]; 65 (8 ): 758-760 PMID28820169 show ga Treatment guidelines for symptomatic polypoidal choroidal vasculopathy (PCV) have been described, but the management of recurrent or recalcitrant PCV is a challenge. The newer anti-vascular endothelial growth factor: aflibercept has shown promise in the treatment of both treatment naive and recalcitrant PCV in studies outside India. We present the minimum 6 months results of intravitreal aflibercept in recurrent and recalcitrant PCV in Indian eyes after multiple injections of bevacizumab/ranibizumab with or without photodynamic therapy. Of 10 eyes, 7 resolved of which 4 recurred needing continued aflibercept. Three of the ten eyes did not show a response. To the best of our knowledge, this is the first report from India in this challenging situation. |Aged [MESH] |Aged, 80 and over [MESH] |Choroid Diseases/diagnosis/*drug therapy [MESH] |Choroid/*blood supply [MESH] |Dose-Response Relationship, Drug [MESH] |Female [MESH] |Fluorescein Angiography [MESH] |Follow-Up Studies [MESH] |Fundus Oculi [MESH] |Humans [MESH] |Intravitreal Injections [MESH] |Male [MESH] |Middle Aged [MESH] |Polyps/diagnosis/*drug therapy [MESH] |Receptors, Vascular Endothelial Growth Factor/*administration & dosage/antagonists & inhibitors [MESH] |Recombinant Fusion Proteins/*administration & dosage [MESH] |Recurrence [MESH] |Retrospective Studies [MESH] |Time Factors [MESH] |Tomography, Optical Coherence [MESH] |Treatment Outcome [MESH]Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculo(epmc).pdf DeepDyve Pubget Overpricing